课题基金 / 基金详情

CONSTRUCTION AND OPTIMIZATION OF ANTIHIV RIBOZYMES

CONSTRUCTION AND OPTIMIZATION OF ANTIHIV RIBOZYMES
抗HIV核酶的构建和优化
批准号:
2065293
负责人:
JOHN MacKenzie BURKE
金额:
$25.18万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-07-01 至 1999-04-30

项目摘要

项目成果

JOHN MacKenzie BURKE的其他基金

相似基金

相关文献

中文摘要
翻译
描述:(改编自申请人的摘要) 这项拟议的研究项目是开发核酶技术, 这一点是接近现实的治疗。 这将使用 发夹核酶是一种小的反式作用RNA酶, 非常适合细胞RNA失活研究。 以前的工作 阐明了发夹状核酶可以被改造成 有效地切割HIV序列,并开发了一种体外选择 通过该方法,针对给定靶序列的核酶活性 可以优化。 这些发现已被用于产生核酶 靶向强烈抑制HIV-1的保守HIV pol序列 在培养的淋巴细胞中复制。 目前建议的具体目标是:(1)严格界定 抗HIV发夹状核酶抗病毒作用位点和机制, 并评估其在体内的底物选择性;(2)开发和评估 一类新的抗艾滋病毒靶点,使用新的信息定义 发夹状核酶的底物特异性。 预计这一 工作将导致(i)明确的证据表明,工程发夹 核酶通过在细胞膜上的位点特异性切割RNA来抑制HIV的复制。 靶向位点,(ii)探索几种新的策略, 发育、细胞内活化和代谢调节 高活性核酶,以及(iii)开发和快速测试 一些潜在的新的抗HIV治疗剂。
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract) The overall goal of this proposed research project is to develop ribozyme technology to the point that it is close to therapeutic reality. This will be done using the hairpin ribozyme which is a small trans-acting RNA enzyme that is highly suitable for cellular RNA inactivation studies. Previous work has elucidated rules by which the hairpin ribozyme can be engineered to efficiently cleave HIV sequences and has developed an in vitro selection method through which ribozyme activity against a given target sequence can be optimized. These findings have been used to generate a ribozyme targeted to a conserved HIV pol sequence that strongly inhibits HIV-1 replication in cultured lymphocytes. The Specific Aims of the current proposal are: (1) Rigorously define the site and mechanism of antiviral action of anti-HIV hairpin ribozymes, and assess their substrate selectivity in vivo; (2) Develop and evaluate a novel class of anti-HIV targets, using new information defining substrate specificity of the hairpin ribozyme. It is expected that this work will result in (i) definitive proof that engineered hairpin ribozymes inhibit HIV replication by site- specific RNA cleavage at the targeted site, (ii) the exploration of several novel strategies for the development, intracellular activation, and metabolic regulation of highly active ribozymes, and (iii) the development and rapid testing of a number of potential new anti-HIV therapeutic agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hammerhead Ribozyme: Active Site Assembly and Structure
Enhancing Protections through Learner-Centered Education
Hammerhead Ribozyme: Active Site Assembly and Structure
Hammerhead Ribozyme: Active Site Assembly and Structure
国内基金
海外基金
基于合成生物标志物的超多重RNA数字化检测平台用于肿瘤精准诊断和分期评估
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    程子译
  • 依托单位:
RNA m6A修饰通过调控FDX1介导的铜死亡参与补阳还五汤抗脑缺血再灌注损伤作用机制的研究
  • 批准号:
    2026JJ81091
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    刘亮
  • 依托单位:
免标记CRISPR-RNA适配体与门逻辑分子诊断新方法研究
  • 批准号:
    2026JJ50010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    应站明
  • 依托单位:
Dead-box解旋酶DDX23通过调控RNA高级结构促进肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    JCZRLH202600588
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: